Related references
Note: Only part of the references are listed.Molecular Imaging of the Paracrine Proangiogenic Effects of Progenitor Cell Therapy in Limb Ischemia
Jae Choon Ryu et al.
CIRCULATION (2013)
A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia
Pawan K. Gupta et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
Paolo Bianco et al.
NATURE MEDICINE (2013)
The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction
Hyunsuk Jeong et al.
STEM CELL RESEARCH & THERAPY (2013)
Vascular Incorporation of Endothelial Colony-Forming Cells Is Essential for Functional Recovery of Murine Ischemic Tissue Following Cell Therapy
Theresa M. Schwarz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia
Aaron Liew et al.
STEM CELL RESEARCH & THERAPY (2012)
Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia A Randomized-Start, Placebo-Controlled Pilot Trial (PROVASA)
Dirk H. Walter et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Cell Therapy for Critical Limb Ischemia Moving Forward One Step at a Time
Rajesh Gupta et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial
Debin Lu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
Xi-Ping Huang et al.
CIRCULATION (2010)
Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia
T Iwase et al.
CARDIOVASCULAR RESEARCH (2005)
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms
T Kinnaird et al.
CIRCULATION RESEARCH (2004)
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
K Le Blanc et al.
EXPERIMENTAL HEMATOLOGY (2003)
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial
E Tateishi-Yuyama et al.
LANCET (2002)
Share Paper
